The global landscape of wellness, metabolic health, and weight management is shifting at an incredible pace
It acts simultaneously on glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, producing significant reductions in body weight and improvements in glycaemic control
Spend over 80/103.20 and get free delivery to UK & Ireland
Tablets produce slower weight loss than injections but fewer people stop them due to side effects
Reporting them early guides care plans, like adjusting the dose or incorporating supportive care to ease the treatment burden
GLP-1R activation improves glucose control via enhanced glucose-stimulated insulin secretion [11,12,13], slowed gastric emptying [13, 14], and decreased plasma glucagon levels [13]